A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors
Kulke MH, Stuart K, Earle CC, Bhargava P, Clark JW, Enzinger PC, Meyerhardt J, Attawia M, Lawrence C, Fuchs S. A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings. 2006.